Skip to main content
editorial
. 2021 Oct 8;321(6):H1005–H1013. doi: 10.1152/ajpheart.00477.2021

Figure 1.

Figure 1.

Annual number of American Journal of Physiology-Heart publications from 1993 to 2020 that used excitation-contraction uncoupling agents [CytoD, BDM (DAM), Bleb] in cardiac optical mapping studies. BDM, 2,3-butanedione monoxime; Bleb, blebbistatin; CytoD, cytochalasin D; DAM, diacetyl monoxime.